Levetiracetam Best Monotherapy for Infants with Epilepsy For over 50% of newborn children determined to have epilepsy with no known reason, it is essential that clinicians know which prescription may be well on the way to control the condition. Hitting the nail on the head early would mean better future results for these infants. So analysts thought about two of the most generally recommended drugs for newborn children with epilepsy whose epilepsy isn't caused by a particular disorder: levetiracetam and phenobarbital. Their discoveries recommend that levetiracetam is more viable than phenobarbital. observational investigation says that following a half year of single- medicate treatment , 40 % of babies who got levetiracetam met criteria for effective result they didn't require a moment hostile to epileptic medication to control their seizures and they moved toward becoming sans seizure inside three months of beginning treatment. Just 16 percent of newborn children
